Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Dividends Paid - Common (2021 - 2025)

Historic Dividends Paid - Common for Ani Pharmaceuticals (ANIP) over the last 5 years, with Q3 2025 value amounting to $344000.0.

  • Ani Pharmaceuticals' Dividends Paid - Common fell 1527.09% to $344000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 381.54%. This contributed to the annual value of $1.6 million for FY2024, which is 0.0% changed from last year.
  • Ani Pharmaceuticals' Dividends Paid - Common amounted to $344000.0 in Q3 2025, which was down 1527.09% from $407000.0 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Dividends Paid - Common ranged from a high of $407000.0 in Q2 2022 and a low of $190000.0 during Q4 2021
  • Its 5-year average for Dividends Paid - Common is $388875.0, with a median of $406000.0 in 2022.
  • In the last 5 years, Ani Pharmaceuticals' Dividends Paid - Common surged by 11421.05% in 2022 and then crashed by 1527.09% in 2025.
  • Ani Pharmaceuticals' Dividends Paid - Common (Quarter) stood at $190000.0 in 2021, then surged by 114.21% to $407000.0 in 2022, then fell by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then fell by 15.27% to $344000.0 in 2025.
  • Its Dividends Paid - Common stands at $344000.0 for Q3 2025, versus $407000.0 for Q2 2025 and $406000.0 for Q1 2025.